Definitive Contract HHSD200201691956C
Award Date
9/30/16
Potential Completion Date
9/29/18
Potential Value
$216K
Federal Agency
CDC Pittsburgh
Awardee
Genome Research LIMITED
Ultimate Awardee
Not listed
NAICS Category
541711 - Research and Development in Biotechnology
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Available for Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Great Britain, United Kingdom
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Clinger Cohen Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The federal contract award is for the preparation and submission of genome data to GenBank, a genetic sequence database. The contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency of the U.S. government. The prime contractor is IG Assets Inc., and the contract has a ceiling value of $6,000.00 with a firm fixed price. The contract does not have a set-aside designation. The award was made on June 7, 2011, with a completion date of July 25,...
The U.S. Department of Health and Human Services (HHS) - National Institutes of Health (NIH) awarded a $5,675.00 firm fixed-price purchase order contract to Medgenome Inc., a small business, for genomic sequencing and data services. The contract has an ultimate completion date of June 30, 2025 and was awarded on August 29, 2024. The contract is not set-aside. Medgenome Inc. provides a range of scientific services, primarily in the field of genomics and lab testing, including genomic...
This is a $145,000.00 firm fixed-price purchase order contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to the Translational Genomics Research Institute (TGen), a non-profit research organization. The contract is for RUN DATA SAMPLES services, with a completion date of September 29, 2024. TGen has previously performed genomic research services for federal agencies under both contracts and grants, including work related to SARS-CoV-2,...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $2.5 million definitive contract to the Scripps Research Institute for genomic sequencing of SARS-CoV-2 to investigate local and cross-border emergence and spread. This contract was awarded under the Centers for Disease Control COVID-19 Broad Agency Announcement, which sought white papers related to developing strategies for protecting communities from COVID-19, including examining the virus's...
This is a firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The contract is for the provision of Genomic Sequencing Kits with a ceiling value of $170,641.14 and a performance period ending on August 28, 2024. The contract does not utilize a set-aside designation. Illumina is the prime contractor and has been awarded multiple federal contracts...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $145,590 purchase order to Clinical Research Sequencing Platform, LLC for clinical genome sequencing services. The prime contractor, Clinical Research Sequencing Platform, LLC, is a division of The Broad Institute, Inc. doing business as Broad Institute of MIT and Harvard. The firm fixed price contract runs from August 30, 2023 through December 31, 2023 to...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm-fixed-price purchase order to Illumina, Inc., a manufacturer of sequencing and genomic analysis solutions, with a potential value of $159,999.10. The contract has a completion date of September 14, 2023 and was awarded on September 15, 2022. Illumina has previously received federal contract awards from agencies such as the NIH, USDA, and VA to provide a range of sequencing systems, reagents, and...
This is a $1,205,149.24 Firm Fixed Price contract awarded by the Centers for Disease Control and Prevention (CDC) to Ginkgo Bioworks, Inc., a biotechnology company based in Boston, Massachusetts. The contract, titled "TRAVELER-BASED GENOMIC SURVEILLANCE," is for the provision of biotechnology services to support the CDC's public health monitoring and emergency response initiatives. The contract has an ultimate completion date of September 19, 2024 and was awarded on August 26, 2024....
The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a firm fixed price purchase order to Oxford Nanopore Technologies Inc. for $0.00. The contract has no set-aside designation and calls for delivery of products or services by June 11, 2020 in support of the agency's genome research efforts. As the leading federal funder and coordinator of genome research, this contract likely provides the Institute with nanopore sequencing...
This is a firm fixed price delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Illumina, Inc. The $24,800 contract is for the provision of various Illumina sequencing systems, reagents, and related services to support genomic sequencing and analysis. No set-aside designations are noted. Illumina has previously received prime contracts and subcontracts from other federal...